Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)
Clinical trial NCT03095651 · COMPLETED
Trial details
- NCT number
- NCT03095651
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-12
- Primary completion
- 2018-01-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.